BioNTech shares upgraded on new cancer drug potential
| IBX50 Index | 21,205 60.36 0.28% |
Under 62% of Bovespa Brazil's investor base is looking to short. The analysis of the overall investor sentiment regarding Bovespa Brazil 50 suggests that many traders are alarmed. Bovespa Brazil's investing sentiment shows overall attitude of investors towards Bovespa Brazil 50.
BioNTech shares upgraded on new cancer drug potential
Read at investing.com
 |
Bovespa Brazil 50 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bovespa Brazil index to make a market-neutral strategy. Peer analysis of Bovespa Brazil could also be used in its relative valuation, which is a method of valuing Bovespa Brazil by comparing valuation metrics with similar companies.
Peers
Bovespa Brazil Related Equities
| GETY | Getty Images | 3.08 | ||||
| IRDM | Iridium Communications | 2.73 | ||||
| ITRN | Ituran Location | 2.65 | ||||
| WIMI | WiMi Hologram | 2.41 | ||||
| ZD | Ziff Davis | 1.94 | ||||
| DH | Definitive Healthcare | 0.21 | ||||
| RDCM | Radcom | 1.00 |